Nasserinejad, K
41  results:
Search for persons X
?
2

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INT..:

Groen, K ; Stege, C ; Nasserinejad, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171775/.  , 2023
 
?
3

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIAT..:

Seefat, M.R ; Stege, C.A.M ; Timmers, G.J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171826/.  , 2023
 
?
4

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN F..:

Groen, K ; Seefat, M ; Nasserinejad, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430988/.  , 2022
 
?
 
?
6

Carfilzomib, Pomalidomide, and Dexamethasone As Second-line..:

Sonneveld P ; Zweegman S ; Cavo M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000886680600006.  , 2022
 
?
8

Prevalence of permanent neonatal hearing impairment: system..:

Bussé, Andrea ; Hoeve, Hans ; Nasserinejad, K...
Bussé , A , Hoeve , H , Nasserinejad , K , Mackey , AR , Simonsz , H & Goedegebure , A 2020 , ' Prevalence of permanent neonatal hearing impairment: systematic review and Bayesian meta-analysis ' , International Journal of Audiology , vol. 59 , no. 6 , pp. 475-485 . https://doi.org/10.1080/14992027.2020.1716087.  , 2020
 
1-15